Startup Insider: Medical Testing’s Golden Age

We have a special treat for you this week. Our First Stage Investor members (click here to sign up) regularly get to hear Andy Gordon and Vin Narayanan interview founders. This week, we’re releasing a very special interview they conducted Friday to the entire Early Investing community.

On Friday, Andy and Vin talked to Jonathan Cohen, the founder and CEO of 20/20 GeneSystems. Andy first presented 20/20 GeneSystems as an investment opportunity to our First Stage Investor members in 2017. In this wide-ranging discussion, Jonathan talks about why medical testing is more important (and more appreciated) than ever, how his startup is helping detect cancer early, why they decided to bring a rapid COVID-19 test to the market, what they’ve learned from that experience, why the startup plans on being listed on StartEngine’s alternative trading system and much more.

We hope you enjoy this taste of First Stage Investor. And thanks for watching.